RPg Family Wealth Advisory’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.38M Sell
16,658
-3,355
-17% -$278K 0.37% 77
2025
Q1
$1.62M Buy
20,013
+2,109
+12% +$171K 0.46% 64
2024
Q4
$1.61M Buy
17,904
+200
+1% +$18K 0.57% 52
2024
Q3
$1.75M Buy
17,704
+663
+4% +$65.5K 0.56% 50
2024
Q2
$1.58M Buy
17,041
+687
+4% +$63.7K 0.52% 52
2024
Q1
$1.55M Buy
16,354
+1,816
+12% +$172K 0.49% 55
2023
Q4
$1.3M Buy
14,538
+674
+5% +$60.2K 0.48% 64
2023
Q3
$1.01M Sell
13,864
-1,820
-12% -$133K 0.42% 65
2023
Q2
$1.3M Buy
15,684
+1,065
+7% +$88.6K 0.52% 57
2023
Q1
$1.11M Buy
14,619
+1,880
+15% +$143K 0.61% 50
2022
Q4
$1.06M Buy
12,739
+5,623
+79% +$467K 0.72% 41
2022
Q3
$596K Hold
7,116
0.31% 59
2022
Q2
$529K Buy
7,116
+96
+1% +$7.14K 0.32% 56
2022
Q1
$631K Buy
7,020
+166
+2% +$14.9K 0.27% 63
2021
Q4
$767K Buy
6,854
+197
+3% +$22.1K 0.3% 54
2021
Q3
$837K Buy
6,657
+289
+5% +$36.3K 0.35% 57
2021
Q2
$862K Buy
+6,368
New +$862K 0.35% 60
2020
Q4
$1.23M Hold
8,719
0.58% 51
2020
Q3
$972K Buy
8,719
+428
+5% +$47.7K 0.51% 53
2020
Q2
$928K Buy
8,291
+1,832
+28% +$205K 0.57% 52
2020
Q1
$500K Buy
6,459
+1,591
+33% +$123K 0.39% 52
2019
Q4
$463K Sell
4,868
-2,381
-33% -$226K 0.27% 69
2019
Q3
$553K Sell
7,249
-47
-0.6% -$3.58K 0.33% 60
2019
Q2
$640K Buy
7,296
+4,682
+179% +$411K 0.38% 52
2019
Q1
$237K Buy
+2,614
New +$237K 0.14% 91
2017
Q3
Sell
-178
Closed -$13.7K 317
2017
Q2
$13.7K Buy
+178
New +$13.7K 0.01% 274